Le 5 cose da sapere sulle CAR-T
CAR-T is a type of therapy in which T lymphocytes taken from a patient are reinfused into their body after being genetically modified in the laboratory to enhance their anti-cancer activity and specifically target tumor cells for selective elimination. What exactly are they, how do they work, and how effective are they in hematological diseases, particularly multiple myeloma? Professor Michele Cavo, Director of the Seragnoli Institute of Hematology at the IRCCS University Hospital of Bologna, answers these and other questions about this new treatment modality.
▶︎
Dott. Claudio Cerchione: Gammopatie Monoclonali e Mieloma Multiplo
▶︎
Mieloma Multiplo sopravvivenza aumentata grazie alle nuove cure
▶︎
Cellule CarT, la prima terapia genica contro il cancro
▶︎
le terapie car t
▶︎
Before you Start or Refuse Cancer Therapy- WATCH THIS!
▶︎
CAR-T Therapy for Multiple Sclerosis Explained by Neurologist
▶︎
Antineoplastic Agents | Clinical Medicine
▶︎
Doctors break down every stage of lymphoma | Cancer: Explained | Macmillan Cancer Support
▶︎
Mieloma multiplo, la guarigione è possibile?
▶︎
Terapie CAR-T: Rivoluzione nel Trattamento dei Tumori con l'immunoterapia cellulare
▶︎
Gammopatia monoclonale di significato incerto: evolve sempre verso un mieloma multiplo?
▶︎
Thymoma: Current Status and Future Directions
▶︎
CAR-T cells in multiple myeloma - Inside Humanitas Cancer Center
▶︎
Alone During a Heart Attack? 3 Emergency Actions That Can Save Your Life!
▶︎
Mieloma multiplo, rimborsata in Italia la terapia CAR-T
▶︎
CAR T Cells: Beating Cancer with the Immune System
▶︎
Terapia con cellule CAR-T, come si gestiscono i possibili effetti collaterali?
▶︎
Multiple Myeloma: Symptoms, Prevention, Causes, Diagnosis
▶︎
STAGE 4 COLON CANCER AT 31 YRS OLD | my diagnosis story part 1
▶︎